×
ADVERTISEMENT

mpox

Clade Ib Mpox Cases Reported in the United States

The first U.S. case of clade I mpox was identified in California through electronic laboratory reporting. Three ...

MARCH 28, 2025

Although Safe, Tecovirimat Proves Ineffective for Treating Clade II Mpox

More data from the STOMP trial presented at CROI 2025, held in San Francisco, confirms that tecovirimat does not ...

MARCH 14, 2025

Co-Circulating Viruses Causing Concern in Mpox Outbreak

The mpox outbreak in the Democratic Republic of Congo has spilled over into Uganda, which borders the DRC, ...

MARCH 14, 2025

What Motivates People to Receive the Mpox Vaccine?

When people are aware that their behavior puts them at risk, some will be motivated to receive mpox vaccination, ...

JANUARY 14, 2025

Tecovirimat is Safe but Did Not Improve Clade I Mpox Resolution in the DRC

The antiviral drug tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I ...

SEPTEMBER 18, 2024

Los Angeles County Tecovirimat Distribution Plan Aided in Mpox Response

The distribution of tecovirimat through hospitals, clinics and pharmacies during the 2022-2023 mpox outbreak was ...

AUGUST 14, 2024

Hiding Sexual Identity May Have Impeded Mpox Care

Openly gay, bisexual and other sexual minority men were more likely than those who concealed their sexual ...

MAY 22, 2024

Asymptomatic Mpox Points to Need for Increased Testing and Vaccination

Healthcare providers should consider early testing of the sexual contacts of people with mpox, regardless of ...

MAY 13, 2024

Previous Smallpox Vaccination Boosts Immunogenicity of Mpox Vaccine

Immunogenicity after mpox vaccination lasted longer among people who had received a smallpox vaccination as a child ...

MAY 1, 2024

Emergency or Not, Mpox Still a Problem for Some

Vaccination should still be recommended to certain at-risk groups, experts say.

APRIL 10, 2024

Jynneos Booster May Improve Immunity Against Mpox in People With HIV

People living with HIV who have a low CD4 T-cell count may benefit from a booster dose of Jynneos vaccine (Bavarian ...

FEBRUARY 13, 2024

ACIP Recommends Jynneos Vaccine for Certain Populations

ACIP recommended the 2-dose Jynneos vaccine series for adults at risk for mpox to increase vaccination and reduce ...

OCTOBER 27, 2023

Load more